9258 Wealth Management’s Fulgent Genetics FLGT Stock Holding History

9258 Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,050	Closed	-$307K	–	370
2021 Q4	$307K	Hold	3,050	–	–	0.07%	282
2021 Q3	$274K	Hold	3,050	–	–	0.07%	279
2021 Q2	$281K	Hold	3,050	–	–	0.08%	276
2021 Q1	$295K	Buy	+3,050	New	+$315K	0.09%	248

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

9258 Wealth Management's FLGT Position: Q1 2022 in Review

9258 Wealth Management sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 3,050 shares — an estimated $307K sold.

9258 Wealth Management first reported a position in FLGT in Q1 2021 and held it in 4 quarters. The position peaked at $307K in Q4 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

9258 Wealth Management reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
9258 Wealth Management sold 3,050 Fulgent Genetics shares in Q1 2022, an estimated $307K.
9258 Wealth Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 4 quarters.
9258 Wealth Management's Fulgent Genetics position peaked at $307K in Q4 2021.
275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on 9258 Wealth Management's 13F filing for Q1 2022, filed 13 May 2022.